{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+%28Lumigan%29&page=2", "query": { "intervention": "Bimatoprost (Lumigan)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 98, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+%28Lumigan%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+%28Lumigan%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T01:08:03.157Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02636946", "title": "A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma", "Open-Angle Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost SR", "type": "DRUG" }, { "name": "Sham Bimatoprost SR", "type": "DRUG" }, { "name": "Selective Laser Trabeculoplasty", "type": "PROCEDURE" }, { "name": "Sham Selective Laser Trabeculoplasty", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 144, "start_date": "2016-02-24", "completion_date": "2021-01-26", "has_results": true, "last_update_posted_date": "2022-02-23", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 21, "location_summary": "Dothan, Alabama • Chandler, Arizona • Redding, California + 17 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Redding", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02636946" }, { "nct_id": "NCT00538304", "title": "A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "bimatoprost eye drops", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 222, "start_date": "2007-11", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2019-04-23", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00538304" }, { "nct_id": "NCT00693420", "title": "Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Eyelashes" ], "interventions": [ { "name": "Bimatoprost 0.03% sterile solution", "type": "DRUG" }, { "name": "vehicle sterile solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 278, "start_date": "2007-04", "completion_date": "2007-12", "has_results": true, "last_update_posted_date": "2013-10-30", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00693420" }, { "nct_id": "NCT00541242", "title": "Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ocular Hypertension", "Glaucoma" ], "interventions": [ { "name": "bimatoprost 0.03% eye drops", "type": "DRUG" }, { "name": "latanoprost 0.005% eye drops", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 586, "start_date": "2007-12", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2011-10-27", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 1, "location_summary": "Newport Beach, California", "locations": [ { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00541242" }, { "nct_id": "NCT01099774", "title": "Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost 0.03% Formulation B Ophthalmic Solution", "type": "DRUG" }, { "name": "Bimatoprost 0.03% Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 597, "start_date": "2010-05-01", "completion_date": "2011-04-29", "has_results": true, "last_update_posted_date": "2019-04-17", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 1, "location_summary": "Newport Beach, California", "locations": [ { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01099774" }, { "nct_id": "NCT06122090", "title": "Treatment of Hypopigmented Scars With Bimatoprost", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Scars", "Hypopigmented Scar", "Hypopigmented Skin", "Burn Scar", "Scarring", "Cicatrix, Hypertrophic", "Cicatrix", "Pigmentation Disorder", "Burns Laser" ], "interventions": [ { "name": "Bimatoprost", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medstar Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2023-07-18", "completion_date": "2025-07-31", "has_results": false, "last_update_posted_date": "2024-05-03", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06122090" }, { "nct_id": "NCT01525173", "title": "A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "0.1% brimonidine tartrate ophthalmic solution", "type": "DRUG" }, { "name": "0.01% bimatoprost ophthalmic solution", "type": "DRUG" }, { "name": "0.2% hypromellose lubricant eye drops", "type": "DRUG" }, { "name": "latanoprost 0.005% ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 137, "start_date": "2012-01", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2013-12-04", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 1, "location_summary": "Deerfield Beach, Florida", "locations": [ { "city": "Deerfield Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01525173" }, { "nct_id": "NCT04499248", "title": "AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Open-angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "AGN-193408 SR", "type": "DRUG" }, { "name": "Lumigan", "type": "OTHER" }, { "name": "Sham Administration", "type": "OTHER" }, { "name": "Lumigan Vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2020-11-16", "completion_date": "2029-04", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 42, "location_summary": "Sun City, Arizona • Glendale, California • Inglewood, California + 38 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Glendale", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04499248" }, { "nct_id": "NCT02448043", "title": "Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nail Growth Cessation", "Intraocular Pressure" ], "interventions": [ { "name": "Bimatoprost 0.01%", "type": "DRUG" }, { "name": "Placebo: saline", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2015-06-04", "completion_date": "2016-05-06", "has_results": true, "last_update_posted_date": "2019-12-13", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 1, "location_summary": "Glenview, Illinois", "locations": [ { "city": "Glenview", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02448043" }, { "nct_id": "NCT05335122", "title": "A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Open Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "OTX-TIC low dose Travoprost Intracameral Implant", "type": "DRUG" }, { "name": "OTX-TIC high dose Travoprost Intracameral Implant", "type": "DRUG" }, { "name": "Durysta, Bimatoprost Intracameral Implant 10 µg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ocular Therapeutix, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2022-03-16", "completion_date": "2025-01-24", "has_results": true, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-10-11T01:08:03.157Z", "location_count": 30, "location_summary": "Dothan, Alabama • Huntington Beach, California • Irvine, California + 27 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05335122" } ] }